Freeze Dried Plasma (FDP) Emergency Use Authorization or FDA Licensed Product

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT9427-26-RFI-704

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Classification Code

6515

Additional Details
Set Aside

NONE

Place of Performance

Maryland, UNITED STATES

SourceSAM
The Defense Health Agency (DHA), operating under the Department of Defense (DoD), has issued a Sources Sought notice to identify potential industry partners capable of supplying Freeze Dried Plasma (FDP) products. This procurement activity is managed by the Operational Medicine (OPMED) division and is focused on sourcing either an FDA-licensed FDP product or one that currently holds an Emergency Use Authorization (EUA) from the Food and Drug Administration. The intent is to assess market capabilities and identify suppliers with products at this advanced stage of regulatory development. The primary objective of this initiative is to enhance the DoD’s operational medical readiness by ensuring access to FDP products that meet stringent safety and efficacy standards, as defined by FDA licensure or EUA status. The anticipated outcome is to establish a reliable supply of FDP for emergency and operational use, supporting the health and survivability of military personnel in diverse and potentially austere environments. Key requirements for interested parties include the ability to provide a freeze dried plasma product that is either fully licensed by the FDA or authorized for emergency use under current FDA guidelines. Respondents must demonstrate that their product is at this regulatory milestone, as products in earlier stages of development are not being considered at this time. The notice does not specify additional technical or performance requirements, nor does it outline expected quantities or delivery schedules, as this is a market research effort rather than a formal solicitation. The procurement is classified under NAICS code 325414, which pertains to Biological Product (except Diagnostic) Manufacturing, and is further identified by Product Service Code 6515, covering medical and surgical instruments, equipment, and supplies. There are no set-aside restrictions associated with this notice, indicating that all qualified vendors, regardless of business size or socioeconomic status, are encouraged to respond. The place of performance for this requirement is Maryland, United States. The contracting activity is managed by the Defense Health Agency, with Timothy Kelly serving as the primary point of contact. Interested parties may direct inquiries or submit capability statements to Mr. Kelly at [email protected]. This notice is currently active, with a response deadline of March 25, 2026. Contractors considering this opportunity should review the official posting on SAM.gov (Opportunity ID: ed19ca96864644109ee2c0d77f1ed018) for any updates or additional instructions. As this is a Sources Sought notice, no attachments or supporting documents are provided at this stage, and no procurement steps or milestones have been outlined. In summary, this market research effort seeks to identify suppliers of FDA-licensed or EUA-authorized freeze dried plasma products to support the Defense Health Agency’s operational medicine mission. Contractors with relevant, compliant products are encouraged to respond and engage with the DHA to inform future procurement strategies.